Is circadian rhythmicity a prerequisite to coma recovery? Circadian recovery concomitant to cognitive improvement in two comatose patients.


Journal

Journal of pineal research
ISSN: 1600-079X
Titre abrégé: J Pineal Res
Pays: England
ID NLM: 8504412

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 05 10 2018
revised: 28 12 2018
accepted: 29 12 2018
pubmed: 12 1 2019
medline: 6 7 2019
entrez: 12 1 2019
Statut: ppublish

Résumé

Circadian rhythmicity (CR) is involved in the regulation of all integrated functions, from sleep-wake cycle regulation to metabolic function, mood and cognition. However, the interdependence of CR, cognition and consciousness has been poorly addressed. To clarify the state of CR in coma and to determine the chronological relationship between its recovery and consciousness after brain lesions, we conducted a longitudinal observational study investigating how the state of CR was chronologically related with the recovery of behavioural wakefulness, cognition and/or awareness. Among 16 acute comatose patients, we recruited two 37-year-old patients with a persistent disorder of consciousness, presenting diencephalic lesions caused by severe traumatic brain injuries. Two biological urinary markers of CR were explored every 2 hours during 24 hours (6-sulfatoxymelatonin, free cortisol) with a dedicated methodology to extract the endogenous component of rhythmicity (environmental light recording, near-constant-routine protocol, control of beta-blockers). They presented an initial absence of rhythmic secretions and a recovered CR 7-8 months later. This recovery was not associated with the restoration of behavioural wakefulness, but with an improvement of cognition and awareness (up to the minimally conscious state). MRI showed a lesion pattern compatible with the interruption of either the main hypothalamic-sympathetic pathway or the accessory habenular pathway. These results suggest that CR may be a prerequisite for coma recovery with a potential but still unproven favourable effect on brain function of the resorted circadian melatonin secretion and/or the functional recovery of the suprachiasmatic nucleus (SCN). Assessing circadian functions by urinary melatonin should be further explored as a biomarker of cognition reappearance and investigated to prognosticate functional recovery.

Identifiants

pubmed: 30633817
doi: 10.1111/jpi.12555
doi:

Substances chimiques

Biomarkers 0
6-sulfatoxymelatonin 2208-40-4
Melatonin JL5DK93RCL
Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12555

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Florent Gobert (F)

Neuro-Intensive Care Unit, Hospices Civils de Lyon, Neurological Hospital Pierre-Wertheimer, Bron, France.
ImpAct Team (Integrative, Multisensory, Perception, Action & Cognition), Lyon Neuroscience Research Centre (Université Claude Bernard Lyon 1, INSERM U1028, CNRS UMR5292), Bron, France.
CAP Team (Cognition Auditive et Psychoacoustique), Lyon Neuroscience Research Center (Université Claude Bernard Lyon 1, INSERM U1028, CNRS UMR5292), Lyon, France.

Jacques Luauté (J)

ImpAct Team (Integrative, Multisensory, Perception, Action & Cognition), Lyon Neuroscience Research Centre (Université Claude Bernard Lyon 1, INSERM U1028, CNRS UMR5292), Bron, France.
Neuro-Rehabilitation Unit, Hospices Civils de Lyon, Neurological Hospital Pierre-Wertheimer, Bron, France.

Véronique Raverot (V)

Hormone Laboratory, Hospices Civils de Lyon, Neurological Hospital Pierre-Wertheimer, Bron, France.

François Cotton (F)

Radiology Unit, Lyon-Sud Hospital, Hospices Civils de Lyon, Pierre-Benite, France.
CREATIS-LRMN (CNRS UMR 5220 - INSERM U630), Villeurbanne, France.

Frédéric Dailler (F)

Neuro-Intensive Care Unit, Hospices Civils de Lyon, Neurological Hospital Pierre-Wertheimer, Bron, France.

Bruno Claustrat (B)

Hormone Laboratory, Hospices Civils de Lyon, Neurological Hospital Pierre-Wertheimer, Bron, France.

Fabien Perrin (F)

CAP Team (Cognition Auditive et Psychoacoustique), Lyon Neuroscience Research Center (Université Claude Bernard Lyon 1, INSERM U1028, CNRS UMR5292), Lyon, France.

Claude Gronfier (C)

Lyon Neuroscience Research Center (CRNL), Integrative Physiology of the Brain Arousal Systems (Waking) team, INSERM UMRS 1028, CNRS UMR 5292, Université Claude Bernard Lyon 1, Université de Lyon, F-69000, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH